Dr. Hanson is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
30 N 1900e School Of Medicine
University Of Utah
Salt Lake City, UT 84108Phone+1 801-581-8812Fax+1 801-585-3377
Summary
- Dr. Kimberly Hanson is an infectious disease specialist in Salt Lake City, UT and is affiliated with University of Utah Health. She received her medical degree from Northwestern University Feinberg School of Medicine and has been in practice 19 years. She specializes in microbiology.
Education & Training
Duke University HospitalFellowship, Infectious Disease, 2004 - 2005- Duke University HospitalFellowship, Medical Microbiology, 2003 - 2004
Dartmouth-Hitchcock/Mary Hitchcock Memorial HospitalResidency, Internal Medicine, 1998 - 2002
Northwestern University The Feinberg School of MedicineClass of 1998
Certifications & Licensure
UT State Medical License 2008 - 2026
NC State Medical License 2002 - 2009- American Board of Internal Medicine Infectious Disease
- American Board of Pathology Medical Microbiology
Clinical Trials
- β-D-Glucan (BDG) Surveillance With Preemptive Anidulafungin vs. Standard Care for Invasive Candidiasis in Surgical Intensive Care Unit (SICU) Patients Start of enrollment: 2008 Jun 01
- Influence of Rifampin Co-Administration on the Pharmacokinetic Profile of Daptomycin Start of enrollment: 2014 May 01
Publications & Presentations
PubMed
- 49 citationsThe Infectious Diseases Society of America Guidelines on the Diagnosis of COVID-19: Antigen Testing (January 2023).Mary K Hayden, Kimberly E Hanson, Janet A Englund, Francesca Lee, Mark J Lee
Clinical Infectious Diseases. 2024-06-27 - The Infectious Diseases Society of America Guidelines on the Diagnosis of COVID-19: Molecular Diagnostic Testing (December 2023).Mary K Hayden, Kimberly E Hanson, Janet A Englund, Mark J Lee, Mark Loeb
Clinical Infectious Diseases. 2024-06-27 - Reply to Kidd et al., "Inconsistencies within the proposed framework for stabilizing fungal nomenclature risk further confusion".Sybren de Hoog, Thomas J Walsh, Sarah A Ahmed, Ana Alastruey-Izquierdo, Barbara D Alexander
Journal of Clinical Microbiology. 2024-04-10
Press Mentions
New Review Article Outlines Potential of SARS-CoV-2 Genetic Sequencing in Patient CareNovember 3rd, 2021- Frequent Covid Tests Urged to Help Curb Spread of Delta VariantAugust 2nd, 2021
- Joint 3i/U2M2 Project Grants Open Pathways for Infectious Disease ResearchApril 29th, 2021
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
